Header Logo

Connection

Alan Go to Time Factors

This is a "connection" page, showing publications Alan Go has written about Time Factors.
Connection Strength

2.665
  1. Implication of Trends in Timing of Dialysis Initiation for Incidence of End-stage Kidney Disease. JAMA Intern Med. 2020 12 01; 180(12):1647-1654.
    View in: PubMed
    Score: 0.149
  2. The Heart Failure Readmission Intervention by Variable Early Follow-up (THRIVE) Study: A Pragmatic Randomized Trial. Circ Cardiovasc Qual Outcomes. 2020 10; 13(10):e006553.
    View in: PubMed
    Score: 0.147
  3. Kidney Function and Potassium Monitoring After Initiation of Renin-Angiotensin-Aldosterone System Blockade Therapy and Outcomes in 2 North American Populations. Circ Cardiovasc Qual Outcomes. 2020 09; 13(9):e006415.
    View in: PubMed
    Score: 0.147
  4. Cumulative Adherence to Secondary Prevention Guidelines and Mortality After Acute Myocardial Infarction. J Am Heart Assoc. 2020 03 17; 9(6):e014415.
    View in: PubMed
    Score: 0.142
  5. Renin-Angiotensin System Blockade after Acute Kidney Injury (AKI) and Risk of Recurrent AKI. Clin J Am Soc Nephrol. 2020 01 07; 15(1):26-34.
    View in: PubMed
    Score: 0.139
  6. Short-Term Outcomes and Factors Associated With Adverse Events Among Adults Discharged From the Emergency Department After Treatment for Acute Heart Failure. Circ Heart Fail. 2017 Dec; 10(12).
    View in: PubMed
    Score: 0.121
  7. Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators. Heart. 2017 04; 103(7):529-537.
    View in: PubMed
    Score: 0.112
  8. Post-discharge Follow-up Characteristics Associated With 30-Day Readmission After Heart Failure Hospitalization. Med Care. 2016 Apr; 54(4):365-72.
    View in: PubMed
    Score: 0.108
  9. High-sensitivity cardiac troponin I and incident coronary heart disease among asymptomatic older adults. Heart. 2016 08 01; 102(15):1177-82.
    View in: PubMed
    Score: 0.108
  10. Incidence and timing of potentially high-risk arrhythmias detected through long term continuous ambulatory electrocardiographic monitoring. BMC Cardiovasc Disord. 2016 Feb 17; 16:35.
    View in: PubMed
    Score: 0.107
  11. The association of gender to cardiovascular outcomes after coronary artery revascularization in patients with end-stage renal disease. Clin Cardiol. 2014 Sep; 37(9):546-51.
    View in: PubMed
    Score: 0.095
  12. Effectiveness and safety of spironolactone for systolic heart failure. Am J Cardiol. 2013 Nov 01; 112(9):1427-32.
    View in: PubMed
    Score: 0.090
  13. Effectiveness and safety of digoxin among contemporary adults with incident systolic heart failure. Circ Cardiovasc Qual Outcomes. 2013 Sep 01; 6(5):525-33.
    View in: PubMed
    Score: 0.090
  14. Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE Study. Circ Cardiovasc Qual Outcomes. 2013 May 01; 6(3):333-42.
    View in: PubMed
    Score: 0.088
  15. Detection of paroxysmal atrial fibrillation by 30-day event monitoring in cryptogenic ischemic stroke: the Stroke and Monitoring for PAF in Real Time (SMART) Registry. Stroke. 2012 Oct; 43(10):2788-90.
    View in: PubMed
    Score: 0.084
  16. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure. Am J Cardiol. 2007 Aug 15; 100(4):690-6.
    View in: PubMed
    Score: 0.059
  17. Acute Kidney Injury, Systemic Inflammation, and Long-Term Cognitive Function: ASSESS-AKI. Clin J Am Soc Nephrol. 2024 Jul 01; 19(7):829-836.
    View in: PubMed
    Score: 0.047
  18. Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure. J Am Heart Assoc. 2020 07 07; 9(13):e014385.
    View in: PubMed
    Score: 0.036
  19. Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2019 12; 12(12):e007612.
    View in: PubMed
    Score: 0.035
  20. Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation. Circ Cardiovasc Qual Outcomes. 2019 11; 12(11):e006212.
    View in: PubMed
    Score: 0.035
  21. Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation. Heart. 2018 11; 104(22):1850-1858.
    View in: PubMed
    Score: 0.031
  22. Pre-admission proteinuria impacts risk of non-recovery after dialysis-requiring acute kidney injury. Kidney Int. 2018 04; 93(4):968-976.
    View in: PubMed
    Score: 0.031
  23. Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation). Circ Arrhythm Electrophysiol. 2017 Nov; 10(11).
    View in: PubMed
    Score: 0.030
  24. Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry. J Am Coll Cardiol. 2017 Sep 12; 70(11):1325-1335.
    View in: PubMed
    Score: 0.030
  25. Heterogeneity in national U.S. mortality trends within heart disease subgroups, 2000-2015. BMC Cardiovasc Disord. 2017 07 18; 17(1):192.
    View in: PubMed
    Score: 0.029
  26. Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation. Clin Cardiol. 2017 Sep; 40(9):746-751.
    View in: PubMed
    Score: 0.029
  27. Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study. Clin J Am Soc Nephrol. 2017 May 08; 12(5):761-771.
    View in: PubMed
    Score: 0.029
  28. Loss of executive function after dialysis initiation in adults with chronic kidney disease. Kidney Int. 2017 04; 91(4):948-953.
    View in: PubMed
    Score: 0.029
  29. Storage Time and Urine Biomarker Levels in the ASSESS-AKI Study. PLoS One. 2016; 11(10):e0164832.
    View in: PubMed
    Score: 0.028
  30. Abrupt Decline in Kidney Function Before Initiating Hemodialysis and All-Cause Mortality: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2016 08; 68(2):193-202.
    View in: PubMed
    Score: 0.027
  31. Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT-AF Registry. Clin Cardiol. 2016 Feb; 39(2):119-25.
    View in: PubMed
    Score: 0.026
  32. Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry. Am Heart J. 2016 Apr; 174:29-36.
    View in: PubMed
    Score: 0.026
  33. Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort. J Am Coll Cardiol. 2015 Jun 30; 65(25):2691-8.
    View in: PubMed
    Score: 0.026
  34. Kansas City Cardiomyopathy Questionnaire Score Is Associated With Incident Heart Failure Hospitalization in Patients With Chronic Kidney Disease Without Previously Diagnosed Heart Failure: Chronic Renal Insufficiency Cohort Study. Circ Heart Fail. 2015 Jul; 8(4):702-8.
    View in: PubMed
    Score: 0.025
  35. Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry. Am Heart J. 2015 Jul; 170(1):141-8, 148.e1.
    View in: PubMed
    Score: 0.025
  36. Challenges of ascertaining national trends in the incidence of coronary heart disease in the United States. J Am Heart Assoc. 2014 Dec 03; 3(6):e001097.
    View in: PubMed
    Score: 0.025
  37. Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin. Am J Cardiol. 2014 Aug 15; 114(4):583-6.
    View in: PubMed
    Score: 0.024
  38. Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2014 May; 167(5):735-42.e2.
    View in: PubMed
    Score: 0.023
  39. Long-term survival after ischemic stroke in patients with atrial fibrillation. Neurology. 2014 Mar 25; 82(12):1033-7.
    View in: PubMed
    Score: 0.023
  40. A longitudinal study of left ventricular function and structure from CKD to ESRD: the CRIC study. Clin J Am Soc Nephrol. 2013 Mar; 8(3):355-62.
    View in: PubMed
    Score: 0.022
  41. Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction. J Am Heart Assoc. 2013 Feb 01; 2(1):e005694.
    View in: PubMed
    Score: 0.022
  42. Longitudinal study of implantable cardioverter-defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter-defibrillators for primary prevention in contemporary practice. Circ Cardiovasc Qual Outcomes. 2012 Nov; 5(6):e78-85.
    View in: PubMed
    Score: 0.021
  43. Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants. Stroke. 2012 Jul; 43(7):1795-9.
    View in: PubMed
    Score: 0.021
  44. Detection of atrial fibrillation after stroke and the risk of recurrent stroke. J Stroke Cerebrovasc Dis. 2012 Nov; 21(8):726-31.
    View in: PubMed
    Score: 0.019
  45. Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int. 2009 Oct; 76(8):893-9.
    View in: PubMed
    Score: 0.017
  46. Insulin resistance independently predicts the progression of coronary artery calcification. Am Heart J. 2009 May; 157(5):939-45.
    View in: PubMed
    Score: 0.017
  47. Glycemic response to newly initiated diabetes therapies. Am J Manag Care. 2007 Nov; 13(11):598-606.
    View in: PubMed
    Score: 0.015
  48. Reducing delay in seeking treatment by patients with acute coronary syndrome and stroke: a scientific statement from the American Heart Association Council on cardiovascular nursing and stroke council. Circulation. 2006 Jul 11; 114(2):168-82.
    View in: PubMed
    Score: 0.014
  49. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study. J Am Soc Nephrol. 2005 Sep; 16(9):2778-88.
    View in: PubMed
    Score: 0.013
  50. Breast vascular calcification and risk of coronary heart disease, stroke, and heart failure. J Womens Health (Larchmt). 2004 May; 13(4):381-9; discussion 390-2.
    View in: PubMed
    Score: 0.012
  51. Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin. Ann Intern Med. 2001 Sep 18; 135(6):393-400.
    View in: PubMed
    Score: 0.010
  52. Prediction of risk for patients with unstable angina. Evid Rep Technol Assess (Summ). 2000 Aug; (31):1-3.
    View in: PubMed
    Score: 0.009

© 2024 Kaiser Permanente